At the RNApp graduate school, young researchers are working to make RNA-based drugs safer and more effective.

RNA epigenetic modifications have uncovered as not only an intermediary structure between DNA and protein or an effector ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...

Moderna (NasdaqGS:MRNA) recently experienced a 17% decline in share price over the past week, a significant downturn that occurs amidst market-wide turbulence triggered by escalating global trade ...

Flagship Pioneering-backed Sail Biomedicines has laid off 12 employees following a review of the company’s organizational ...

A genetic mutation in horses that would typically halt protein production has become a molecular asset. Researchers at Johns ...

According to Benzinga Pro, Moderna's peer group average for short interest as a percentage of float is 5.27%, which means the company has more short interest than most of its peers. Did you know that ...

Why not all African countries should venture into vaccine business ANALYSIS | The African Union has embarked on one of its ...

A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...

The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...